GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] France — has anyone got a straight answer on telehealth — 45 comments in the full submission. View in context.
864
c/compounding·submitted 1 months ago by u/honest_syringe

[Question] France — has anyone got a straight answer on telehealth

Questionbranch of 9 comments

Question in the title, detail here: France — has anyone got a straight answer on telehealth. Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history. Concentration on the compounded vial was different from what I had been using and I nearly…

Read the full submission and all 45 comments →

This branch

9 comments, started 1 months ago
u/clara_danquah62 points·1 months ago

The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.

replysharereportpermalink
u/honest_syringeOP46 points·1 months ago

Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing.

replysharereportpermalink
u/rekha_mwangi38 points·1 months ago

if a clinic will not name the facility, that is your answer

replysharereportpermalink
u/ffmi_watcher14 points·1 months ago

ask which facility, then ask for their testing

replysharereportpermalink
u/milos_mensa3 points·1 months ago·edited

Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.

replysharereportpermalink
u/swirl_dont_shakereconstitution91 points·1 months ago·edited

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

replysharereportpermalink
u/yannick_petrov20 points·1 months ago

What concentration is on the label, and does it match what you were expecting?

replysharereportpermalink
u/fatima_kowalski11 points·1 months ago

shortage status changes and the whole arrangement changes with it

replysharereportpermalink
u/honest_syringeOP6 points·1 months ago·edited

Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.